Literature DB >> 18791552

Glaucoma: an area of darkness.

R A Hitchings1.   

Abstract

This review of Primary Open Angle Glaucoma looks at the management of the condition today. It does this by looking at the following areas: (a) the size of the problem; (b) the position of IOP, with respect to its elevation and fluctuation; (c) optic nerve head changes; and (d) visual function changes. In doing so, it contrasts what is known now with ideas and concepts that were prevalent at the time of the two previous Bowman lecturers, Duke Elder and Drance, as well as noting concepts about the disease that were current at the time of William Bowman. The review concludes by suggesting challenges in this area that lie ahead.

Entities:  

Mesh:

Year:  2008        PMID: 18791552     DOI: 10.1038/eye.2008.260

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  Utility of digital stereo images for optic disc evaluation.

Authors:  Richard A Stone; Gui-Shuang Ying; Denise J Pearson; Mayank Bansal; Manika Puri; Eydie Miller; Judith Alexander; Jody Piltz-Seymour; William Nyberg; Maureen G Maguire; Jayan Eledath; Harpreet Sawhney
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study.

Authors:  Jennifer M Burr; Marion K Campbell; Susan E Campbell; Jillian J Francis; Alexandra Greene; Rodolfo Hernández; Debra Hopkins; Sharon K McCann; Luke D Vale
Journal:  BMC Med Res Methodol       Date:  2011-04-21       Impact factor: 4.615

3.  Study of Optimal Perimetric Testing In Children (OPTIC): developing consensus and setting research priorities for perimetry in the management of children with glaucoma.

Authors:  Dipesh E Patel; Phillippa M Cumberland; Bronwen C Walters; Joseph Abbott; John Brookes; Beth Edmunds; Peng Tee Khaw; Ian Christopher Lloyd; Maria Papadopoulos; Velota Sung; Mario Cortina-Borja; Jugnoo S Rahi
Journal:  Eye (Lond)       Date:  2021-06-21       Impact factor: 4.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.